This is a preview of subscription content, log in via an institution to check access.
Notes
The study was funded by Pharmacosmos A/S.
Reference
Pollock RF, et al. An Economic Analysis of Ferric Derisomaltose versus Ferric Carboxymaltose in the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease in Norway, Sweden, and Finland. ClinicoEconomics and Outcomes Research : 7 Jan 2021. Available from: URL: https://doi.org/10.2147/CEOR.S284959
Rights and permissions
About this article
Cite this article
Ferric derisomaltose saves costs in treatment of iron-deficiency anaemia in IBD. PharmacoEcon Outcomes News 870, 7 (2021). https://doi.org/10.1007/s40274-021-7410-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7410-z